
Lessons On Leadership From Fatherhood
Dr. Ujjwal Ramtekkar is the Chief Medical Officer at LifeStance Health.
As a father and a C-suite executive, I've learned many of my most valuable leadership lessons from moments spent with my children. Parenting has shaped my leadership style just as much as my professional experiences have influenced how I show up as a 'pappa.' This Father's Day, I'm reflecting on a few lessons that apply equally at home and at work and how leading with trust, empathy and presence has helped me grow stronger as both a parent and leader.
My son taught me one of my most vivid lessons about trust as I was teaching him how to ride a bike. We started by removing the balancing wheels, me running alongside as he wobbled. Then came the most difficult part: letting go. I thought I needed to trust that he'd figure it out. But the moment he looked at me and said, 'Dad, I knew you'd be there when I fell,' I realized I had it backward. It was him who needed to trust me.
It's no secret that trust is important in both parenting and leadership, and maintaining it requires modeling consistency, honesty and self-awareness. Not every moment requires intervention, and just because you could intervene does not always mean you should. As with parenting, effective leadership often means knowing when to provide guidance and resources and when to step back. If we immediately fix problems for our teams or our children simply because we can, then we deny them the opportunity to develop their own agency or problem-solving skills. Growth happens when we allow people to make mistakes, adjust and succeed on their own terms, with the trust and knowledge that someone has their back. Of course, stepping in is sometimes necessary, especially depending on one's life or career stage. But the goal should be to create a fair, fail-safe environment where mistakes become growth opportunities and not setbacks.
Effective leadership extends beyond the workplace to include how we lead our personal lives. One thing I've adopted is a mindset shift from 'work-life' balance to 'life-work' balance. What this looks like in practice is making time every day for what matters to you personally and treating it as non-negotiable. Family dinner. Therapy. Exercise. Reading. The things that fulfill you deserve to be a part of your daily life. When you prioritize your health, family and the things that recharge you, it sets the tone of respect—first for yourself and then for your teams. A 2024 advisory from the Office of the Surgeon General on the mental health and well-being of parents noted that many parents and caregivers feel undervalued when they make tradeoffs to prioritize family. Dr. Vivek Murthy, former U.S. surgeon general, called for a shift in cultural norms to help them thrive. As leaders, I believe we have a responsibility to normalize life-work balance for our teams and help this shift become a reality.
As a child psychiatrist, I've seen how the presence and modeling of a father or father figure supports positive emotional and behavioral outcomes for children. As an adult psychiatrist, one of the most common regrets I've heard from 'successful' fathers is not being there for their children when it counted most. Presence matters. Being skilled at multitasking is often worn as a badge of honor. However, I believe the ability to single-task and be fully present and focused on one thing at a time is far better for relationships, long-term performance and well-being.
I suggest creating intentional boundaries at work and home. When you're at work, give undivided attention and focus on your work. When you're at home, silence your phone and step away from your inbox. It's not easy, especially in leadership roles, but feeling like you have to be constantly available makes prioritizing and modeling balance all the more important. Work hard and strive for success, but never lose sight of staying present with your family.
As parents and leaders, we are the role models: We're always being watched. It's not what we say that matters most, but what we do. There's a saying in medicine: 'Patients don't care how much you know until they know how much you care.'
The same holds true in leadership. To me, empathy is about consistently demonstrating that you care about your teammates. One small but meaningful habit I've adopted is asking my teammates a simple question: 'How are things going for you today?' It's a deliberately broad question to invite a reflective, personal response. While their instinct is often to share something work-related, I gently clarify, 'Not about work.' That distinction serves as a reminder that I'm genuinely interested in them and their well-being as people, not just as colleagues.
While these lessons have helped me grow as both a leader and parent, none would be successful without embodying one core value: kindness. At my son's school, the motto is 'choose kind.' It's a daily reminder that kindness isn't a natural trait but a decision we make. Be kind as a parent. Be kind as a leader. Be kind to yourself. Use good conduct and demonstrate positive values to build trust everywhere you go. Model good behavior, and everything else will fall into place.
Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Hill
2 hours ago
- The Hill
Minnesota lawmakers approve social media mental health warning measure
Minnesota lawmakers have approved a measure requiring social media platforms to display a warning label, cautioning about the negative impacts of its use on mental health. The bill, which the legislature sent to Minnesota Gov. Tim Walz (D) on Thursday, requires platforms to display the warning each time a user accesses the site. Users must acknowledge the 'potential for harm' and choose 'to proceed to the social media platform despite the risk.' The measure specifically notes the warning label cannot be exclusively provided in a platform's terms and conditions or include 'extraneous' information reducing the visibility of the warning. The label must also feature resources to address the potential negative impacts associated with social media, including a website and phone number for a national suicide prevention and mental health crisis hotline. The push to include warning labels on the apps has gained steam amid increasing concerns about the impacts of social media, particularly on children. Former surgeon general Vivek Murthy called for social media warning labels last year after previously issuing an advisory about the impact of social media on kids' mental health. 'The mental health crisis among young people is an emergency — and social media has emerged as an important contributor,' Murthy wrote in an op-ed published by The New York Times last June. 'A surgeon general's warning label, which requires congressional action, would regularly remind parents and adolescents that social media has not been proved safe,' he added. Congress has also considered legislation to establish stronger protections for kids online, including the Kids Online Safey Act (KOSA). KOSA, which was reintroduced last month by Sens. Marsha Blackburn (R-Tenn.) and Richard Blumenthal (D-Conn.), seeks to create regulations for the features that tech companies offer kids online and reduce the addictive nature and mental health effects of these platforms. The bill passed the Senate last year but ultimately hit roadblocks in the House.
Yahoo
2 hours ago
- Yahoo
AMGEN AND FOOTBALL LEGEND BARRY SANDERS HIGHLIGHT DANGERS OF BAD CHOLESTEROL IN NEW DOCUMENTARY
The Making of a Heart Attack Educates Viewers About High LDL-C—a Major, but Modifiable, Risk Factor for Heart Attack and Stroke THOUSAND OAKS, Calif., June 13, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the launch of The Making of a Heart Attack, a documentary that sheds light on the cardiovascular disease crisis in the United States, where every 40 seconds someone has a heart attack or stroke.1 Experience the full interactive Multichannel News Release here: The Making of a Heart Attack features renowned former football running back, Barry Sanders, who reveals he experienced a heart attack on Father's Day in 2024 and what he's learned since then about high LDL or "bad" cholesterol—a leading, but often hidden risk factor for cardiovascular events.2-7 "I've spent my life as a professional athlete taking care of my body, but I had no idea I was living with a silent risk that could lead to a heart attack," said Sanders. "My message to other people is simple: don't wait. Get your LDL-C tested and talk to your doctor. Knowing your number is an important step to understanding your risk."7 More than 40% of adults with high LDL-C in the U.S. do not know their levels are high.8 The documentary educates viewers about LDL-C and how it can lead to a buildup of plaque in the arteries, putting individuals at risk of a cardiovascular event.5 "We know that high LDL-C is one of the leading, yet most modifiable, risk factors for heart attack and stroke.1 However, the cardiovascular disease public health crisis continues," said Paul Burton, M.D., senior vice president and chief medical officer at Amgen. "The Making of a Heart Attack should be a wake-up call for everyone. Amgen is committed to leading change by increasing LDL-C testing and encouraging patients and the entire healthcare system to act with urgency to overcome inertia and address this issue." Featured alongside Sanders sharing their own stories of living with cardiovascular disease are Hyvelle Ferguson-Davis, founder of Heart Sistas; Tara Robinson, CEO of the Black Heart Association; Gigi Campos, a WomenHeart Champion; and her father, Ponciano Gari. Sara Collins, M.D., FACC, an interventional cardiologist and member of the Association of Black Cardiologists, provides her expert medical perspective throughout. The documentary is part of Amgen's broader ambition to cut the number of heart attacks and strokes in the U.S. in half by 2030. Working with advocacy leaders, medical societies, healthcare systems and research institutions, Amgen is advancing efforts to drive earlier LDL-C testing, expand access to care and improve health outcomes. Watch The Making of a Heart Attack on June 14, 2025, at 1 p.m. ET on A&E (check local listings). The documentary will be available to watch online at beginning June 16, 2025 and will be featured at the Cannes Lions International Festival of Creativity 2025. To learn more about LDL-C, especially if you have cardiovascular disease, including how to get a free cholesterol test, visit Be sure to talk to your doctor about your results. About AmgenAmgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit and follow Amgen on X, LinkedIn, Instagram, YouTube and Threads. Amgen Forward-Looking StatementsThis news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeOne Medicines Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast), our acquisitions of ChemoCentryx, Inc. or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, and any potential strategic benefits, synergies or opportunities expected as a result of such acquisition), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed, and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions, including those resulting from geopolitical relations and government actions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico, and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our sustainability objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook, 609-251-1407 (media) Justin Claeys, 805-313-9775 (investors) REFERENCES Martin SS, et al. Circulation. 2024;149:e347-e913. Grundy SM, et al. J Am Coll Cardiol. 2019;73:3168-3209. McKinley EC, et al. Cardiovasc Drugs Ther. 2023;37:107-116. Wilkinson MJ, et al. J Am Heart Assoc. 2023;12:11:e028892:1-22. Understanding and Managing LDL (Bad) Cholesterol. American Heart Association. Accessed June 2025. Underberg J, et al. Postgrad Med. 2022;134:752-762. Heart Disease Risk Factors. Centers for Disease Control and Prevention. December 2, 2024. Accessed June 2025. Sayed A, et al. JAMA Cardiol. 2023;8(12):1185–1187. View original content: SOURCE Amgen Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Barry Sanders features in documentary about heart attack experience
During Father's Day weekend last year, Detroit Lions legend Barry Sanders suffered a heart attack. For Father's Day this year, Sanders is featured in a new documentary exploring what risks and lifestyle choices are behind heart attacks and strokes. "The Making of a Heart Attack" is a new documentary film set to premiere Saturday at 1 p.m. on A&E. In it, Sanders will talk to four other people "who faced a heart attack or stroke to uncover the hidden risks, lasting impact and what they want others to know," according to the film's description on A&E's website. On June 21 last year, Sanders shared a statement via social media announcing that he had "experienced a health scare related to my heart." .@Lions @NFL @NFLPA @ProFootballHOF @HeismanTrophy @okstate — Barry Sanders (@BarrySanders) June 21, 2024 BARRY SANDERS: Saquon Barkley likens his eventual retirement to Lions' legend's: 'Out of nowhere' 'It was unexpected and served as a reminder of the importance of staying vigilant about our physical well-being, even when we are feeling fine,' Sanders' statement read. 'I am grateful for the amazing doctors, nurses and other healthcare professionals for providing me with needed care. My family and I are thankful for your prayers and support during this time.' In a recent interview with The Athletic, Sanders said that he had no idea the heart attack was coming. As a former athlete who worked out consistently and stayed in shape, he was not aware of other factors or habits that could have led to the cardiovascular event. Even when he had suffered the heart attack, he was not aware it had happened. Sanders told The Athletic that it felt like a similar sensation to heartburn, but he eventually drove himself to the emergency room when it wouldn't go away. Sanders said his goal with this new documentary is to educate more people about the potential risks that can lead to – and the warnings that precede – heart attacks. He also wanted to explore why "the system, including healthcare professionals and patients, aren't catching the signs early enough." MORE BARRY SANDERS: Hall of Famer says Lions' turnaround has been 'miraculous' The film's description reads: "When it comes to cardiovascular disease, recognizing the risks is the first step to taking action." Sanders told The Athletic that "life since his heart attack has been good." The former Lions running back played in the NFL for 10 years and finished his career a six-time All-Pro and three-time Offensive Player of the Year award-winner. Sanders also won the NFL MVP award after the 1997 season, his penultimate year in the league. He was inducted into the Pro Football Hall of Fame in 2004. This article originally appeared on USA TODAY: Barry Sanders shares heart attack experience in new documentary